Survival and Prognosis After Carbon-Ion Radiotherapy in Patients With NSCLC

医学 碳离子放射治疗 放射治疗 肿瘤科 心理干预 毒性 内科学 总体生存率 精神科
作者
Chen-Pi Li,Ru‐Yin Tsai,Hui‐Chin Chang,Shuo‐Yan Gau
出处
期刊:Journal of Thoracic Oncology [Elsevier BV]
卷期号:19 (3): 507-508 被引量:1
标识
DOI:10.1016/j.jtho.2023.11.019
摘要

In the recent study by Kubo et al., 1 Kubo N. Suefuji H. Nakajima M. et al. Five-year survival outcomes after carbon-ion radiotherapy for operable stage I non-small cell lung cancer: a Japanese national registry study (J-CROS-LUNG). J Thorac Oncol. 2024; 19: 491-499 Abstract Full Text Full Text PDF Google Scholar the authors provided real-world information regarding the utilization of carbon-ion radiotherapy (CIRT) for treating operable stage I NSCLC. It was stated that CIRT could provide patients with positive 5-year overall survival and local control rates. Moreover, low associated toxicity levels were observed in this study. On the basis of the findings presented in the current study, the potential viability of CIRT as an alternative to surgical and other interventions for patients with NSCLC could be further evaluated. Five-Year Survival Outcomes After Carbon-Ion Radiotherapy for Operable Stage I NSCLC: A Japanese National Registry Study (J-CROS-LUNG)Journal of Thoracic OncologyVol. 19Issue 3PreviewThe standard therapy for stage I NSCLC is surgery, but some operable patients refuse this option and instead undergo radiotherapy. Carbon-ion radiotherapy (CIRT) is a type of radiotherapy. The Japanese prospective nationwide registry study on CIRT began in 2016. Here, we analyzed real-world clinical outcomes of CIRT for operable patients with stage I NSCLC. Full-Text PDF Open AccessResponse to Letter to the EditorJournal of Thoracic OncologyVol. 19Issue 3PreviewWe appreciate the careful evaluations and concerns raised by Li et al.1 Regarding differences in patient characteristics between the histologically confirmed and nonhistologically confirmed groups, the proportion of patients at stage IB was significantly lower in the nonhistologically confirmed group (6% versus 19%, p = 0.041). Overall survival, cause-specific survival, and progression-free survival, as evaluated by a Cox proportional hazards model, did not differ between the two groups (Table 4, Supplementary Tables 1 and 2). Full-Text PDF

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
WYNN094发布了新的文献求助30
1秒前
2秒前
在水一方的应助被even采纳,获得10
2秒前
fb12000发布了新的文献求助10
3秒前
Akim的应助被贾文浩采纳,获得10
4秒前
u245792完成签到,获得积分10
4秒前
u996067完成签到,获得积分10
5秒前
2026221709发布了新的文献求助10
7秒前
7秒前
8秒前
u620348完成签到,获得积分10
8秒前
u360016完成签到,获得积分10
9秒前
10秒前
10秒前
小蘑菇的应助被Cindy采纳,获得10
10秒前
研友_851KE8发布了新的文献求助30
11秒前
orixero的应助被康少采纳,获得10
12秒前
12秒前
12秒前
u266829完成签到,获得积分10
12秒前
WYNN094完成签到,获得积分10
13秒前
桐桐的应助被369ninja采纳,获得10
14秒前
u202114完成签到,获得积分10
14秒前
研友_VZG7GZ的应助被璇璇采纳,获得10
14秒前
u721406完成签到,获得积分10
14秒前
15秒前
yy关注了科研通微信公众号
16秒前
u912093完成签到,获得积分10
16秒前
17秒前
17秒前
夏末发布了新的文献求助10
17秒前
u308479完成签到,获得积分10
18秒前
19秒前
20秒前
u305068完成签到,获得积分10
20秒前
小于发布了新的文献求助10
21秒前
22秒前
victor完成签到,获得积分0
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184508
求助须知:如何正确求助?哪些是违规求助? 9573479
关于积分的说明 21831986
捐赠科研通 7781752
什么是DOI,文献DOI怎么找? 3434372
关于科研通互助平台的介绍 2558482
邀请新用户注册赠送积分活动 2480962